Fetal Bovine Serum Market Growth Outlook Through 2024-2033

Overview and Scope
Fetal bovine serum refers to a typical element of animal cell culture media that is utilized to support the growth of eukaryotic cells cultured in vitro. It is obtained by harvesting bovine fetuses from pregnant cows who were about to be slaughtered. FBS is frequently obtained with a cardiac puncture without the use of any type of anesthesia.

Sizing and Forecast
The fetal bovine serum market size has grown strongly in recent years. It will grow from $1095.25 billion in 2023 to $1176.47 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to expansion of biopharmaceutical industry, rise in cell-based therapies, quality and consistency requirements.

The fetal bovine serum market size is expected to see strong growth in the next few years. It will grow to $1644.06 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing adoption of cell therapies, emergence of advanced therapeutics, focus on animal-free alternatives, strategic supplier-customer relationships. Major trends in the forecast period include focus on quality and traceability, global collaboration and partnerships, strategic mergers and acquisitions, customized fetal bovine serum products, regulatory compliance and ethical sourcing.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/fetal-bovine-serum-global-market-report 

Segmentation & Regional Insights
The fetal bovine serum market covered in this report is segmented –

1) By Product: Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum, Exosome Depleted, Stem Cell, Other Products
2) By Application: Drug Discovery, Cell Culture Media, In Vitro Fertilization, Human and Animal Vaccine Production, Diagnostics, Other Applications
3) By End-User: Research and Academic Institutes, Biotechnology and Pharmaceutical Industry, Other End-Users

North America was the largest region in the fetal bovine serum market in 2023. Asia-Pacific recorded the fastest growth during the forecast period. The regions covered in the fetal bovine serum market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4109&type=smp 

Major Driver Impacting Market Growth 
The increase in demand for biopharmaceuticals is expected to drive the growth of the fetal bovine serum market in the forecast period. A biopharmaceutical is a medicinal product that is derived from biological sources such as animals, humans, and microorganisms using biotechnology. Fetal bovine serum (FBS) is the most widely used substitute for animal cell culture media. Pharmaceutical firms, diagnostic laboratories, and researchers rely heavily on FBS for much of their cell culture requirements in biologics research. In 2022, ProClinical Limited, a UK-based lifesciences service and consulting company, sales for the company's pharmaceuticals and vaccines segments added up to US$36.15mn, an increase of 11% YOY. Therefore, the rising demand for biopharmaceuticals propels the growth of the fetal bovine serum market.

Key Industry Players
Major companies operating in the fetal bovine serum market report are Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare, Corning Incorporated, Cytiva, VWR International, Sartorius AG, Bio-Techne Corporation, Atlas Biologicals Inc., R&D Systems Inc., Atlanta Biologicals Inc., Cyagen Biosciences, GenClone Inc., Gemini Bio-Products, Access Biologicals LLC, Nucleus Biologics, ZenBio Inc., Biowest, Wellington Laboratories Inc., Bovogen Biologicals Pty Ltd., TCS Biosciences Ltd., J R Scientific Inc., Rocky Mountain Biologicals Inc., Tissue Culture Biologicals, Moregate Biotech, Cell Applications Inc., Altogen Biosystems, Axil Scientific Pte Ltd., Animal Technologies Inc., PAN- Biotech, PAA Laboratories GmbH, Peak Serum Inc., Biochrom GmbH

The fetal bovine serum market report table of contents includes:

1. Executive Summary
2. Fetal Bovine Serum Market Characteristics
3. Fetal Bovine Serum Market Trends And Strategies
4. Fetal Bovine Serum Market - Macro Economic Scenario
5. Global Fetal Bovine Serum Market Size and Growth
.
.
.
32. Global Fetal Bovine Serum Market Competitive Benchmarking
33. Global Fetal Bovine Serum Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Fetal Bovine Serum Market
35. Fetal Bovine Serum Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info 

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company 
Twitter: https://twitter.com/tbrc_info 
Facebook: https://www.facebook.com/TheBusinessResearchCompany 
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ 
Blog: https://blog.tbrc.info/ 
Healthcare Blog: https://healthcareresearchreports.com/ 
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model